Review



mpda nanoparticles  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress mpda nanoparticles
    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded <t>Gal-MPDA</t> for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Mpda Nanoparticles, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 165 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpda nanoparticles/product/MedChemExpress
    Average 96 stars, based on 165 article reviews
    mpda nanoparticles - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Metformin alleviates aging-associated periodontitis via NRF2-mediated restoration of the IRE1α dependent unfolded protein response"

    Article Title: Metformin alleviates aging-associated periodontitis via NRF2-mediated restoration of the IRE1α dependent unfolded protein response

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.03.060

    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded Gal-MPDA for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Figure Legend Snippet: Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded Gal-MPDA for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.

    Techniques Used: Fluorescence, Incubation, Staining, CCK-8 Assay

    In vivo therapeutic effect of the TAM-GM@Met on mice with an aging-associated periodontitis model. (A) Schematic illustration of the therapeutic process on the D-gal induced aging mice periodontitis model. (B) Micro-CT reconstructions and buccal-palatal sectional views of maxillary molars and evaluation of the distance from the CEJ to the ABC. (C, D) Mice periodontal tissue sections prepared for H&E staining (C) and Masson's trichrome staining (D). (E) Schematic of TAM-GM@Met preparation. TAM hydrogel incorporates galactose-coated MPDA nanoparticles (GM) to target senescent cells for metformin delivery. Metformin activates NRF2, leading to transcriptional upregulation of IRE1α, restoration of the UPR, and suppression of SASP in PDLSCs. ns, not significant; TAM, tannic acid and Ag-MOFs based hydrogel; MPDA, mesoporous polydopamine; UPR, unfolded protein response. Data are presented as means ± SEM (n = 5 per subgroup). ∗∗∗P < 0.001.
    Figure Legend Snippet: In vivo therapeutic effect of the TAM-GM@Met on mice with an aging-associated periodontitis model. (A) Schematic illustration of the therapeutic process on the D-gal induced aging mice periodontitis model. (B) Micro-CT reconstructions and buccal-palatal sectional views of maxillary molars and evaluation of the distance from the CEJ to the ABC. (C, D) Mice periodontal tissue sections prepared for H&E staining (C) and Masson's trichrome staining (D). (E) Schematic of TAM-GM@Met preparation. TAM hydrogel incorporates galactose-coated MPDA nanoparticles (GM) to target senescent cells for metformin delivery. Metformin activates NRF2, leading to transcriptional upregulation of IRE1α, restoration of the UPR, and suppression of SASP in PDLSCs. ns, not significant; TAM, tannic acid and Ag-MOFs based hydrogel; MPDA, mesoporous polydopamine; UPR, unfolded protein response. Data are presented as means ± SEM (n = 5 per subgroup). ∗∗∗P < 0.001.

    Techniques Used: In Vivo, Micro-CT, Staining



    Similar Products

    96
    MedChemExpress mpda nanoparticles
    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded <t>Gal-MPDA</t> for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Mpda Nanoparticles, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpda nanoparticles/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    mpda nanoparticles - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Topscience Co Ltd mpda-peg nanoparticles
    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded <t>Gal-MPDA</t> for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Mpda Peg Nanoparticles, supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpda-peg nanoparticles/product/Topscience Co Ltd
    Average 90 stars, based on 1 article reviews
    mpda-peg nanoparticles - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    BioMimetic Therapeutics mesoporous polydopamine (mpda) nanoparticles
    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded <t>Gal-MPDA</t> for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Mesoporous Polydopamine (Mpda) Nanoparticles, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesoporous polydopamine (mpda) nanoparticles/product/BioMimetic Therapeutics
    Average 90 stars, based on 1 article reviews
    mesoporous polydopamine (mpda) nanoparticles - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    BioMimetic Therapeutics mesoporous polydopamine nanoparticles (mpda nps)
    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded <t>Gal-MPDA</t> for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.
    Mesoporous Polydopamine Nanoparticles (Mpda Nps), supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesoporous polydopamine nanoparticles (mpda nps)/product/BioMimetic Therapeutics
    Average 90 stars, based on 1 article reviews
    mesoporous polydopamine nanoparticles (mpda nps) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded Gal-MPDA for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.

    Journal: Bioactive Materials

    Article Title: Metformin alleviates aging-associated periodontitis via NRF2-mediated restoration of the IRE1α dependent unfolded protein response

    doi: 10.1016/j.bioactmat.2026.03.060

    Figure Lengend Snippet: Senescence-targeted, antibacterial, and hemostatic properties of composite hydrogels. (A) Fluorescence images of young and senescent PDLSCs (D-gal and LPS pretreated) incubated with Nile red (NR)-loaded Gal-MPDA for the indicated time periods. (B) Confocal fluorescence images showing the subcellular localization of GM@Nir in D-gal and LPS-induced senescent PDLSCs and cross-sectional analysis. Lysosome, Lyso tracker; Nuclei, Hoechst. (C) Live-dead staining for PDLSCs cells on day 1,3,5. (D) The viability of PDLSCs cells assessed by CCK-8 assay cocultured with composite hydrogels on day 1,3,5. (E) Representative optical images of the Hemolytic test after treating mouse blood with TA, TAM-GM, or TAM-GM@Met, followed by quantification analysis. (F) Live/dead staining of E. coli, S. aureus and P. gingivalis . ns, not significant. Data are presented as means ± SEM (n = 3 per subgroup). ∗∗∗P < 0.001.

    Article Snippet: For fluorescence labeling, Nile red (HY-D0718, MCE) was added to 1 mg/mL MPDA nanoparticles and stirred at room temperature in the dark for 12 h. Then, galactan was added at a ratio of 1:2 with MPDA and stirred for another 12 h in the dark at room temperature.

    Techniques: Fluorescence, Incubation, Staining, CCK-8 Assay

    In vivo therapeutic effect of the TAM-GM@Met on mice with an aging-associated periodontitis model. (A) Schematic illustration of the therapeutic process on the D-gal induced aging mice periodontitis model. (B) Micro-CT reconstructions and buccal-palatal sectional views of maxillary molars and evaluation of the distance from the CEJ to the ABC. (C, D) Mice periodontal tissue sections prepared for H&E staining (C) and Masson's trichrome staining (D). (E) Schematic of TAM-GM@Met preparation. TAM hydrogel incorporates galactose-coated MPDA nanoparticles (GM) to target senescent cells for metformin delivery. Metformin activates NRF2, leading to transcriptional upregulation of IRE1α, restoration of the UPR, and suppression of SASP in PDLSCs. ns, not significant; TAM, tannic acid and Ag-MOFs based hydrogel; MPDA, mesoporous polydopamine; UPR, unfolded protein response. Data are presented as means ± SEM (n = 5 per subgroup). ∗∗∗P < 0.001.

    Journal: Bioactive Materials

    Article Title: Metformin alleviates aging-associated periodontitis via NRF2-mediated restoration of the IRE1α dependent unfolded protein response

    doi: 10.1016/j.bioactmat.2026.03.060

    Figure Lengend Snippet: In vivo therapeutic effect of the TAM-GM@Met on mice with an aging-associated periodontitis model. (A) Schematic illustration of the therapeutic process on the D-gal induced aging mice periodontitis model. (B) Micro-CT reconstructions and buccal-palatal sectional views of maxillary molars and evaluation of the distance from the CEJ to the ABC. (C, D) Mice periodontal tissue sections prepared for H&E staining (C) and Masson's trichrome staining (D). (E) Schematic of TAM-GM@Met preparation. TAM hydrogel incorporates galactose-coated MPDA nanoparticles (GM) to target senescent cells for metformin delivery. Metformin activates NRF2, leading to transcriptional upregulation of IRE1α, restoration of the UPR, and suppression of SASP in PDLSCs. ns, not significant; TAM, tannic acid and Ag-MOFs based hydrogel; MPDA, mesoporous polydopamine; UPR, unfolded protein response. Data are presented as means ± SEM (n = 5 per subgroup). ∗∗∗P < 0.001.

    Article Snippet: For fluorescence labeling, Nile red (HY-D0718, MCE) was added to 1 mg/mL MPDA nanoparticles and stirred at room temperature in the dark for 12 h. Then, galactan was added at a ratio of 1:2 with MPDA and stirred for another 12 h in the dark at room temperature.

    Techniques: In Vivo, Micro-CT, Staining